SymBio Pharmaceuticals Limited (SYMQY)
SymBio Pharmaceuticals Limited operates in the Medical - Pharmaceuticals industry of the Healthcare sector, headquartered in Tokyo, TY, JP. The stock last traded at $0.56, up 0.00% on the session, giving a market capitalisation of $26.4M. On trailing twelve-month figures it carries a trailing P/E of -0.71, a net margin of -532.9%. Its beta of 0.53 implies it has historically moved less than the broad market.
SymBio Pharmaceuticals Ltd. engages in the pharmaceutical business. It researches, develops, manufactures, and sells new drugs focusing on the areas of oncology, hematology, and autoimmune diseases. The company was founded by Fuminori Yoshida on March 25, 2005 and is headquartered in Tokyo, Japan.
SymBio Pharmaceuticals Limited is most often compared with the following Healthcare names: